Saudi Central Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Saudi Central Bank's REGN Position: Q2 2026 in Review
Saudi Central Bank increased its Regeneron Pharmaceuticals (REGN) stake by 91% in Q2 2026, buying an estimated $2.36M and bringing the position to 7,273 shares worth $4.54M. The position accounts for 0.06% of the portfolio, ranked #195.
Saudi Central Bank first reported a position in REGN in Q1 2025 and has held it in 3 quarters since. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Saudi Central Bank held 7,273 shares of Regeneron Pharmaceuticals worth $4.54M as of Q2 2026.
- Saudi Central Bank bought 3,461 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.36M.
- Regeneron Pharmaceuticals made up 0.06% of Saudi Central Bank's portfolio in Q2 2026, its #195 holding.
- Saudi Central Bank first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.